Ascendis Pharma Says UK Approves YORVIPATH For Treatment Of Adults With Chronic Hypoparathyroidism

RTTNews | 484 dias atrás
Ascendis Pharma Says UK Approves YORVIPATH For Treatment Of Adults With Chronic Hypoparathyroidism

(RTTNews) - Danish pharmaceutical company Ascendis Pharma A/S (ASND) announced that the United Kingdom's Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH (palopegteriparatide; developed as TransCon PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism

The MHRA has also granted YORVIPATH orphan drug status. YORVIPATH is a prodrug of parathyroid hormone (PTH 1-34) administered once daily.

MHRA approval of YORVIPATH is based on the same dossier submitted with Ascendis Pharma's Marketing Authorisation Application to the European Medicines Agency, which led to European Commission authorization of YORVIPATH in the European Union in November 2023.

The orphan status provides 10 years of market exclusivity in Great Britain with respect to similar medicinal products in the approved orphan indication of chronic adult hypoparathyroidism.

TransCon PTH is also in development for the treatment of adults with chronic hypoparathyroidism in the United States, Japan, and other countries.

Marcadores : ASND
read more
U.S. Weekly Jobless Claims Rise More Than Expected

U.S. Weekly Jobless Claims Rise More Than Expected

First-time claims for U.S. unemployment benefits rose by much more than expected in the week ended August 16th, according to a repot released by the Labor Department on Thursday.
RTTNews | 16 minutos atrás
FTSE 100 Slips Ahead Of Speeches At Jackson Hole Symposium

FTSE 100 Slips Ahead Of Speeches At Jackson Hole Symposium

U.K. stocks are drifting down a bit on Thursday with investors largely staying cautious, digesting flash survey data on regional manufacturing and services sector activity, and looking ahead to the Jackson Hole Symposium.
RTTNews | 1h 34min atrás
CAC 40 Moderately Lower

CAC 40 Moderately Lower

French stocks are exhibiting weakness on Thursday in cautious trade, with investors awaiting speeches from central bank chiefs at the Jackson Hole Symposium, which gets underway later in the day. Investors are also digesting flash survey figures on regional manufacturing and services sector activity in the month of August.
RTTNews | 2h 0min atrás
Eurozone Private Sector Expands At Fastest Pace In 15 Months

Eurozone Private Sector Expands At Fastest Pace In 15 Months

Eurozone private sector expanded at the fastest pace in 15 months in August on stronger growth in manufacturing output despite challenges posed by U.S. trade tariffs. The HCOB flash composite output index climbed more-than-expected to 51.1 in August from 50.9 in July, survey results from S&P Global revealed Thursday. The score was seen at 50.7.
RTTNews | 2h 4min atrás
DAX Down Marginally

DAX Down Marginally

German stocks are down in negative territory on Thursday with investors making cautious moves while looking ahead to Fed Chair Jerome Powell's speech at the Jackson Hole Symposium for clues about the central bank's likely move on rate cuts this year.
RTTNews | 2h 17min atrás
Sensex, Nifty Extend Gains For Sixth Day On GST Optimism

Sensex, Nifty Extend Gains For Sixth Day On GST Optimism

Indian shares extended gains for a sixth day running on Thursday as investors continued to remain optimistic about S&P's rating upgrade for India, improving Sino-India relations and the Centre's plan to rationalize Goods and Services Tax (GST).
RTTNews | 2h 32min atrás